Menopause and the metabolic syndrome: The study of women's health across the nation

Archives of Internal Medicine

Volumn 168, Issue 14, 2008, Pages 1568-1575

  Janssen, Imke ^a   Powell, Lynda H ^a   Crawford, Sybil ^b   Lasley, Bill ^c   Sutton Tyrrell, Kim ^d  

^a RUSH UNIVERSITY   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ADULT; AGING; ARTICLE; BODY MASS; CLIMACTERIUM; EDUCATIONAL STATUS; ETHNICITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MARRIAGE; MENOPAUSE; METABOLIC SYNDROME X; PREMENOPAUSE; PRIORITY JOURNAL; SMOKING;

CONFIDENCE INTERVALS; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MENOPAUSE; METABOLIC SYNDROME X; MIDDLE AGED; MORBIDITY; ODDS RATIO; RETROSPECTIVE STUDIES; RISK FACTORS; SEX HORMONE-BINDING GLOBULIN; TESTOSTERONE; UNITED STATES; WOMEN'S HEALTH;

EID: 49449119100     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinte.168.14.1568     Document Type: Article

References (40)

1. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285(19):2486-2497.
2. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the Third National Health and Nutrition Examination Survey. JAMA. 2002;287(3):356-359.
3. Rosamond W, Flegal K, Friday G, et al; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics - 2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee [published correction appears in Circulation. 2007;115(5):e172]. Circulation. 2007;115(5):e69-e171. doi :10.1161/CIRCULATIONAHA.106.179918.
4. Kannel WB. Metabolic risk factors for coronary heart disease in women: perspective from the Framingham Study. Am Heart J. 1987;114(2):413-419.
5. Kannel WB, Hjortland MC, McNamara PM, Gordon T. Menopause and risk of cardiovascular disease. Ann Intern Med. 1976;85(4):447-452.
6. Gohlke-Bärwolf C. Coronary artery disease: is menopause a risk factor? Basic Res Cardiol. 2000;95(suppl 1):I77-I83.
7. Tejada C, Strong JP, Montenegro MR, Restrepo C, Solberg LA. Distribution of coronary and aortic atherosclerosis by geographic location, race, and sex. Lab Invest. 1968;18(5):509-526.
8. Yen S, Jaffe R, Barbieri R. Reproductive Endocrinology: Physiology, Pathophysiology, and Clinical Management. 5th ed. Philadelphia, PA: WB Saunders Co; 1999.
9. Anderson DC. Sex-hormone binding globulin. Clin Endocrinol (Oxf). 1974;3(1):69-96.
10. Burger HG, Dudley EC, Cui J, Dennerstein L, Hopper JL. A prospective longitudinal study of serum testosterone, dehydroepiandrosterone sulfate, and sex hormone-binding globulin levels through the menopause transition. J Clin Endocrinol Metab. 2000;85(8):2832-2838.
11. Lasley BL, Santoro N, Randolf JF, et al. The relationship of circulating dehydroepiandrosterone, testosterone, and estradiol to stages of the menopausal transition and ethnicity. J Clin Endocrinol Metab. 2002;87(8):3760-3767.
12. Do KA, Green A, Guthrie JR, Dudley EC, Burger HG, Dennerstein L. Longitudinal study of risk factors for coronary heart disease across the menopausal transition. Am J Epidemiol. 2000;151(6):584-593.
13. Guthrie JR, Taffe JR, Lehert P, Burger HG, Dennerstein L. Association between hormonal changes at menopause and the risk of a coronary event: a longitudinal study. Menopause. 2004;11(3):315-322.
14. Sowers MR, Jannausch M, Randolph JF, et al. Androgens are associated with hemostatic and inflammatory factors among women at the mid-life. J Clin Endocrinol Metab. 2005;90(11):6064-6071.
15. Bonora E, Kiechl S, Willeit J, et al; Bruneck Study. Carotid atherosclerosis and coronary heart disease in the metabolic syndrome: prospective data from the Bruneck Study. Diabetes Care. 2003;26(4):1251-1257.
16. Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001;24(4):683-689.
17. Malik S, Wong ND, Franklin SS, et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation. 2004;110(10):1245-1250.
18. Carr MC. The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metab. 2003;88(6):2404-2411.
19. de Aloysio D, Gambacciani M, Meschia M, et al. The effect of menopause on blood lipid and lipoprotein levels. Atherosclerosis. 1999;147(1):147-153.
20. Peters HW, Westendorp ICD, Hak AE, et al. Menopausal status and risk factors for cardiovascular disease. J Intern Med. 1999;246(6):521-528.
21. Fukami K, Koike K, Hirota K, Yoshikawa H, Miyake A. Perimenopausal changes in serum lipids and lipoproteins: a 7-year longitudinal study. Maturitas. 1995;22(3):193-197.
22. Torng PL,Su TC, Sung FC, et al. Effects of menopause on intraindividual changes in serum lipids, blood pressure, and body weight: the Chin-Shan Community Cardiovascular Cohort Study. Atherosclerosis. 2002;161(2):409-415.
23. Akahoshi M, Soda M, Nakashima E, Shimaoka K, Seto S, Yano K. Effects of menopause on trends of serum cholesterol, blood pressure, and body mass index. Circulation, 1996;94(1):61-66.
24. Haffner SM, Valdez RA. Endogenous sex hormones: impact on lipids, lipoproteins, and insulin. Am J Med. 1995;98(1A):40S-47S.
25. Pugeat M, Moulin P, Cousin P, et al. Interrelations between sex hormone-binding globulin (SHBG), plasma lipoproteins and cardiovascular risk. J Steroid Biochem Mol Biol. 1995;53(1-6):567-572.
26. Sutton-Tyrrell K, Wildman RP, Matthews KA, et al; SWAN Investigators. Sex hormone-binding globulin and the free and rogen index are related to cardiovascular risk factors in multiethnic premenopausal and perimenopausal women enrolled in the Study of Women Across the Nation (SWAN). Circulation. 2005;111(10):1242-1249.
27. Santoro N, Torrens J, Crawford S, et al. Correlates of circulating androgens in mid-life women: the Study of Women's Health Across the Nation. J Clin Endocrinol Metab. 2005;90(8):4836-4845.
28. Sowers MC, Sternfeld B, Morganstein D, et al. SWAN: a multicenter, multiethnic, community-based cohort study of women and the menopausal transition. In: Lobo RMR, Kelsey J. eds. Menopause: Biology and Pathobiology. San Diego, CA: Academic Press; 2000:175-188.
29. Steiner P, Freidel J, Bremner W, Stein E. Standardization of micromethods for plasma cholesterol, triglyceride and HDL-cholesterol with the lipid clinics' methodology [abstract]. J Clin Chem Clin Biochem. 1981;19:850.
30. Warnick GR. Albers JJ. A comprehensive evaluation of the heparin-manganese precipitation procedure for estimating high density lipoprotein cholesterol. J Lipid Res. 1978;19(1):65-76.
31. Deurenberg-Yap M, Yian T, Kai C, Deurenberg P, van Staveren WA. Manifestation of cardiovascular risk factors at low levels of body mass index and waist-to-hip ratio in Singaporean Chinese. Asia Pac J Clin Nutr. 1999;8(3):177-183.
32. Ko GT, Chan J, Cockram C, Woo J. Prediction of hypertension, diabetes, dyslipidaemia or albuminuria using simple anthropometric indexes in Hong Kong Chinese. Int J Obes Relat Metab Disord. 1999;23(11):1136-1142.
33. World Health Organization/International Association for the Study of Obesity/International Obesity Taskforce. The Asia-Pacific perspective: redefining obesity and its treatment. http://www.diabetes.com.au/pdf/ obesity_report.pdf. Accessed December 21, 2006.
34. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C; American Heart Association; National Heart, Lung, and Blood Institute. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation. 2004;109(3):433-438.
35. Gurka MJ. Selecting the best linear mixed model under REML. Am Stat. 2006;60(1):19-26.
36. Ainy E, Mirmiran P, Zahedi Asl S, Azizi F. Prevalence of metabolic syndrome during menopausal transition Tehranian women: Tehran Lipid and Glucose Study (TLGS). Maturitas. 2007;58(2):150-155.
37. Burger HG. The endocrinology of the menopause. Maturitas. 1996;23(2):129-136.
38. Rozenbaum H. Critique of the evidence from large trials of hormone replacement therapy. Int Congr Ser. 2004;1266:139-150.
39. Ding EL, Song Y, Malik VS, Liu S. Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA. 2006;295(11):1288-1299.
40. Kok HS, van Asselt KM, van der Schouw YT, et al. Heart disease risk determines menopausal age rather than the reverse. J Am Coll Cardiol. 2006;47(10):1976-1983.